drugset / Trial / NCT04405518

Impact of Two Guided Transfusion Strategies on Blood Product Requirements in Liver Transplantation.

NCT04405518

Phase 4 Unknown 188 enrolled Antoni Sabaté Pes
RandomizedParallel-groupDouble-blindTreatment

Summary

It is a national multicentre clinical study, where 3 hospitals are involved: Bellvitge University Hospital, Clinic Hospital of Barcelona and Cruces Hospital of Bilbao). It is a randomized study based on the Hemoglobin value of the patient with a 1:1 ratio, parallel groups, controlled and single blind, in patients undergoing an orthotopic liver transplant, confirming previously that the participants fulfill all the inclusion criteria and none of exclusion.

Timeline

Start
2019-06-17
Primary completion
2021-11-02
Completion
2022-10-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Fibrinogen Concentrate Human Protein / enzyme biologic

Indications